With the 2024 US Presidential Election having come to a close, Wall Street can now focus on the future of artificial intelligence, the Federal Reserve's interest rate cut cycle...
Keep Reading →
November 20 - News
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
Keep Reading →
November 18 - Hedge Funds, News
Many investors continue to be worried about Incyte’s financial prospects when the patent for the company’s blood cancer medication, Jakafi, expires in 2028.
Keep Reading →
November 16 - News, Stock Analysis
Incyte Corporation (NASDAQ:INCY) Q3 2024 Earnings Call Transcript October 29, 2024Incyte Corporation misses on earnings expectations.
Keep Reading →
October 31 - News, Transcripts
Incyte Corporation (NASDAQ:INCY) Q2 2024 Earnings Call Transcript July 30, 2024Incyte Corporation misses on earnings expectations.
Keep Reading →
July 31 - News, Transcripts
Incyte Corporation misses on earnings expectations. Reported EPS is $0.746 EPS, expectations were $0.88.
Keep Reading →
May 1 - News, Transcripts
In this piece, we will take a look at the 12 best S&P 500 stocks to buy according to analysts.
Keep Reading →
March 31 - News, Quantitative Investing
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
In this article, we will take a look at the 5 biotech stocks with huge potential.
Keep Reading →
March 8 - Hedge Funds, News
Incyte Corporation misses on earnings expectations. Reported EPS is $1.06 EPS, expectations were $1.21.
Keep Reading →
February 14 - News, Transcripts
In this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds.
Keep Reading →
December 20 - Hedge Funds, News
In this article, we discuss the 13 most promising healthcare stocks according to analysts.
Keep Reading →
December 19 - Hedge Funds, News
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
Keep Reading →
December 18 - Market Movers, News
Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutics for hematology and oncology.
Keep Reading →
November 16 - Hedge Funds, News
In this piece, we will take a look at the 12 biggest healthcare stocks in Jim Simons' stock portfolio.
Keep Reading →
November 13 - Hedge Funds, News
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
Keep Reading →
November 9 - Industries, Lists, News
Operator: Hello, and welcome to the Incyte Third Quarter Earnings Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Keep Reading →
November 1 - News, Transcripts
In this piece, we will take a look at five cheap biotechnology stocks that smart investors are piling into.
Keep Reading →
October 20 - Hedge Funds
In this article, we shall cover the top 30 oncology companies in the world.
Keep Reading →
October 13 - Business, Hedge Funds, Lists, News
In this article, we will be taking a look at the 13 best beaten down stocks to buy now.
Keep Reading →
September 20 - Hedge Funds, News
In this article, we discuss 15 worst performing biotech stocks in 2023.
Keep Reading →
August 8 - Hedge Funds, News, Stock Analysis
Operator: Hello and welcome to the Incyte Second Quarter Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Keep Reading →
August 2 - News, Transcripts
Operator: Hello and welcome to the Incyte First Quarter 2023 Earnings Call and Webcast. A question-and-answer session will follow the formal presentation.
Keep Reading →
May 4 - News, Transcripts
Operator: Hello, and welcome to the Incyte Fourth Quarter and Full Year Financial Results Conference Call and webcast. As a reminder, this conference is being recorded.
Keep Reading →
February 9 - News, Transcripts
In this article, we will be taking a look at 12 cheap biotech stocks to buy.
Keep Reading →
January 25 - Hedge Funds, News
In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks.
Keep Reading →
December 31 - Hedge Funds, News
In this article, we will take a look at some important pharma stock picks of Steven Boyd's Armistice Capital.
Keep Reading →
October 7 - Hedge Funds, News
In this article, we will take a look at the 10 stocks that were recently downgraded by analysts.
Keep Reading →
August 22 - Hedge Funds, News
In this piece, we will take a look at five biotechnology stocks to buy according to billionaire David E. Shaw.
Keep Reading →
April 2 - Hedge Funds, News
Hedge fund titan Clifford Asness joined traders in slamming the London Metal Exchange after the platform cancelled trades – a move that may have helped stem losses at a fund...
Keep Reading →
March 11 - Hedge Funds, Insider Trading
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 867 13F filings that hedge funds and well-known value investors are required to file ...
Keep Reading →
February 6 - Hedge Funds, News
Billionaire investor Ray Dalio has said the Federal Reserve's tightening of monetary policy in 2022 shouldn't derail the economic expansion, but is likely to weigh heavily on "...
Keep Reading →
January 7 - Hedge Funds, Insider Trading
In this article you are going to find out whether hedge funds think Incyte Corporation (NASDAQ:INCY) is a good investment right now.
Keep Reading →
December 8 - Hedge Funds, News
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Keep Reading →
October 12 - Hedge Funds, News
In this article we take a look at five stocks on the move on Wednesday.
Keep Reading →
September 22 - Market Movers, News
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Keep Reading →
July 6 - Hedge Funds, News
In this article we discuss the 5 best pharmaceutical stocks to buy according to Cathie Wood.
Keep Reading →
June 2 - Hedge Funds, News
At Insider Monkey, we pore over the filings of nearly 887 top investment firms every quarter, a process we have now completed for the latest reporting period.
Keep Reading →
April 7 - Hedge Funds, News
In this article we discuss the 5 best BioTech stocks to buy for 2021.
Keep Reading →
April 5 - Hedge Funds, News
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
Keep Reading →
December 21 - Hedge Funds, News
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Keep Reading →
September 15 - Hedge Funds, News
Bill Ackman is putting a modern-day spin on a centuries-old financial innovation with the special purpose acquisition company he plans to take public.
Keep Reading →
July 8 - Hedge Funds, Insider Trading
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
July 8 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
June 4 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Keep Reading →
May 4 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors’ minds right now. It should be.
Keep Reading →
March 11 - Hedge Funds, News
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Keep Reading →
December 26 - Hedge Funds, News
Last year's fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by ...
Keep Reading →
December 3 - Hedge Funds, News
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money ...
Keep Reading →
October 15 - Hedge Funds, News
Is Incyte Corporation (NASDAQ:INCY) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing days ...
Keep Reading →
June 13 - Hedge Funds, News
